Resmed Inc’s recently made public that its Chief Financial Officer Sandercock Brett unloaded Company’s shares for reported $0.23 million on Mar 10 ’25. In the deal valued at $230.36 per share,1,000 shares were sold. As a result of this transaction, Sandercock Brett now holds 90,864 shares worth roughly $20.25 million.
Then, Ghoshal Kaushik sold 9,745 shares, generating $2,332,096 in total proceeds. Upon selling the shares at $239.31, the Chief Commercial Officer, SaaS now owns 9,725 shares.
Before that, Farrell Michael J. sold 8,009 shares. Resmed Inc shares valued at $1,835,692 were divested by the Chief Executive Officer at a price of $229.20 per share. As a result of the transaction, Farrell Michael J. now holds 455,472 shares, worth roughly $101.53 million.
Morgan Stanley initiated its Resmed Inc [RMD] rating to an Overweight in a research note published on March 19, 2025; the price target was $280. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Goldman began covering RMD with “Buy” recommendation on January 16, 2025. Piper Sandler started covering the stock on January 10, 2025. It rated RMD as “a Neutral”.
Price Performance Review of RMD
On Monday, Resmed Inc [NYSE:RMD] saw its stock jump 1.46% to $222.91. Over the last five days, the stock has lost -0.81%. Resmed Inc shares have fallen nearly -2.53% since the year began. Nevertheless, the stocks have risen 15.87% over the past one year. While a 52-week high of $263.05 was reached on 01/30/25, a 52-week low of $172.19 was recorded on 03/21/25. SMA at 50 days reached $234.60, while 200 days put it at $230.39.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 220.81, which if violated will result in even more drops to 218.70. On the upside, there is a resistance level at 224.56. A further resistance level may holdings at 226.21. The Relative Strength Index (RSI) on the 14-day chart is 44.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.94, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.68%. Stochastics %K at 15.45% indicates the stock is a buying.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-02-28, growing by 0.43 million shares to a total of 8.73 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 8.3 million shares. There was a rise of 4.93%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 13, 2024 when Stifel began covering the stock and recommended ‘”a Hold”‘ rating along with a $250 price target.
